Security key
090628207
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 203,581
- Total 13F value
- $171,443
- Share change
- +203,581
- SEC-reported price per share
- $0.84
- Number of holders
- 5
- Value change
- +$171,443
- Number of buys
- 5
Report period
Q3 2023
Institutions
5
Top holders
5
BGLC full security history
Ownership snapshot
Full 13F holder table
BioNexus Gene Lab Corp SEC filings
BioNexus Gene Lab Corp company facts
Broader feeds
Ownership snapshot
Top reported holders of BGLC - BioNexus Gene Lab Corp - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Tai Tan Liong
Disclosed value leader
—
Comparable rows
0/2
Latest evidence
19 Jul 2023
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
2 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Tai Tan Liong's linked filing trail.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Tai Tan Liong |
3/4/5
Chief Operating Officer, Director
|
—
denominator unverified
|
—
12,500,460 shares
|
— | 19 Jul 2023 |
| Wei Li Leong |
3/4/5
Chief Financial Officer
|
—
denominator unverified
|
—
4,797,709 shares
|
— | 19 Jul 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
203,581
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
0
Q3 2023 holders
5
Holder diff
5
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|